Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndromeKelly S. Chien, Guillermo Garcia‐Manero, Courtney D. DiNardo et al.|British Journal of Haematology|2021Cited by 64